chugai

You are now moving to an external website.
Disclaimer
This link will lead you to leave the website of Chugai Pharma Taiwan; the content of the linked website you choose (links, changes, or updates in this website) is no longer the responsibility of Chugai Pharma Taiwan. Chugai Pharma Taiwan does not take any legal responsibility for the information transmitted by this linked website.This link is for your convenience only, and any link does not mean that Chugai Pharma Taiwan endorses or approves its website content.

Access the link

News
Learn More
2025.07.24
BIO Asia-Taiwan: International Pharma Giants Including Chugai Gather for Cross-Sector Innovation and Health Transformation

At BIO Asia–Taiwan 2025, Plenary Session 3 Panel Discussion brought together leading voices in pharma, biotech, and clinical innovation to explore “The Value of Innovation for a Healthier Taiwan.” Moderated by Dr. Johnsee Lee, Chairman of BIO Asia–Taiwan 2025, the panel examined how innovative science, policy alignment, and cross-sector collaboration are shaping Taiwan’s health ecosystem. Panelists included Yuji Habara, President & General Manager of Chugai Pharma Taiwan; Tina Graves, VP and General Manager of GSK Taiwan; Sayaka Fukura, Deputy Head of the Clinical Operations Division at CMIC; and Luke Bi, Executive Director and Head of China BioA and APAC LCMS at Labcorp. Each speaker brought distinct insights to a common challenge: how to unlock the value of innovation for real-world health outcomes.

Learn More
2025.07.01
Chugai Celebrates Centennial with Grand Family Day Event

Chugai Pharma Taiwan, a century-old enterprise (Chugai Pharmaceutical CO.,LTD.), grandly held its "100th Anniversary Family Day" event on June 29th at Yuanshan Flora Expo Park. The celebration brought together nearly 200 employees, retirees, and their families from across Taiwan to witness this glorious milestone moment together. The event was filled with warmth and gratitude.

The birth of a century-old enterprise is no coincidence. Since its establishment, Chugai has weathered changing times and market fluctuations while steadfastly adhering to its "patient-centered" philosophy. Through continuous innovation and steady growth, the company has remained resilient in the fiercely competitive pharmaceutical industry. This Family Day event was not only a celebration but also a heartfelt expression of gratitude to all employees and their families, representing the most touching manifestation of corporate culture.

Learn More
2025.03.28
Chugai Pharma Taiwan (CPT) officially announces its rejoining of the "2025 TALENT, in Taiwan" alliance for sustainable talent development.

Embracing talent, we can do even better. Talent sustainability has always been a goal we value. To create a more diverse, equal, and inclusive workplace, we are officially announcing again that Chugai Pharma Taiwan is joining the "2025 TALENT, in Taiwan, Taiwan Talent Sustainability Action Alliance."

Learn More
2025.03.24
Chugai Pharma Taiwan Partners with Blueseeds to Promote Sustainability and Adopt Organic Herb Farms

This year, Chugai Pharma Taiwan (CPT) has officially partnered with Blueseeds, a local Taiwanese sustainability brand, to adopt and support organic herb farms, reinforcing the company's commitment to corporate sustainability (ESG). Recently, company executives traveled to Taitung to attend the official adoption ceremony, meet with contract farmers, and experience firsthand the natural beauty of the organic herb fields.

Learn More
2025.02.10
Chugai Pharma Taiwan Wins the "Procurement Innovation Pioneer Award," Supporting Taipei's Startup Development

Chugai Pharma Taiwan has been honored with the "Procurement Innovation Pioneer Award" by the Taipei City Government, recognizing its proactive efforts in procuring products and services from local startups and small and medium-sized enterprises (SMEs). This achievement underscores the company’s commitment to fostering innovation and contributing to Taipei's industrial development.

Learn More
2025.01.01
Mr. Yuji Habara assumes the President of Chugai Pharma Taiwan

Chugai Pharma Taiwan convened its board of directors meeting in December of 2024, during which all board members unanimously resolved to appoint Mr. Yuji Habara as the new President, effective January 1st of 2025.

With extensive management experience and profound expertise in the pharmaceutical and biotechnology industries, President Yuji Habara is expected to lead Chugai Pharma Taiwan toward continued steady progress in achieving the group's vision. Under his leadership, the company will not only bring innovative products to patients but also actively contribute to society, safeguard human health and well-being, and strive for excellence.


Learn More
2024.12.30
Chugai Pharma Taiwan won the Ministry of Economic Affairs "Buying Power” Procurement Award for two consecutive years

Chugai Pharma Taiwan (CPT) is dedicated to fulfilling its corporate social responsibilities. In addition to engaging in charitable endeavors, it takes a cautious approach when evaluating supplier qualifications, opting for top-quality and eco-friendly products. Through the implementation of responsible purchasing practices, it has received commendation from the Ministry of Economic Affairs, earning the distinguished "2024 Buying Power Procurement Award".

Learn More
2024.11.01
Chugai Pharma Taiwan’s Penghu Charity Cycling—Riding with Love and Ocean Breezes
Learn More
2024.07.09
Chugai Pharma Taiwan Receives 2024 Asia Responsible Enterprise Awards for Third Consecutive Year
Learn More
2024.05.20
Chugai Pharma Taiwan: Innovation beyond imagination in health care (The Japan Times)
Read More